HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

12th Edition of International Conference on

Neurology and Neurological Disorders

June 22-24, 2026 | Barcelona, Spain

Neurogenerative Disease States

Neurogenerative Disease States

Neurodegenerative diseases are a group of debilitating disorders caused by the degeneration of brain cells that affect an individual's physical, cognitive, and psychosocial functioning. These diseases are typically progressive, meaning the symptoms become increasingly severe over time, and can be life-threatening. While there is no cure for most neurodegenerative diseases, treatments can be used to slow their progression and improve the quality of life for individuals living with these conditions. Common neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). Alzheimer's disease is the most common cause of dementia, affecting millions and often leading to significant cognitive decline. Symptoms of Parkinson's disease include tremor, rigidity, slow movement, and impaired balance. Huntington's disease is a hereditary disorder characterized by movement, behavioral, and cognitive symptoms. Finally, ALS, also known as Lou Gehrig's disease, is a motor neuron disease that leads to progressive disability. Because neurodegenerative diseases affect many vital functioning areas, diagnosing and managing these diseases is complex. Treatment options include medications, physical and occupational therapy, lifestyle changes, and, in some cases, surgery. In most cases, however, there is no cure; thus, the aim of treatment is to slow the progression of the disease while managing symptoms. Additionally, psychotherapeutic interventions such as cognitive behavioral therapy (CBT) and supportive counseling are used to reduce anxiety and depression that can occur due to the consequences of the disease. Ultimately, living with a neurodegenerative disease can be a difficult journey; however, there is hope. With early diagnosis, individuals can benefit from treatments to manage symptoms, slow disease progression, and improve quality of life. Furthermore, supportive care from family, friends, and medical professionals can offer much-needed emotional and psychological support.

Committee Members
Speaker at Neurology and Neurological Disorders 2026 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2026 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2026 - W S El Masri

W S El Masri

Keele University, United Kingdom
Tags

Submit your abstract Today

Watsapp